Undecimal Bio Launches With $18M Oversubscribed Seed Round
Undecimal Bio launches with an oversubscribed $18 million seed round to solve the 'liver trap' that blocks siRNA drugs from reaching organs beyond the liver.
Topic
Topic
Undecimal Bio launches with an oversubscribed $18 million seed round to solve the 'liver trap' that blocks siRNA drugs from reaching organs beyond the liver.